TLRY - Tilray, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.19 (+0.43%)
At close: 4:00PM EDT

44.88 +0.47 (1.06%)
After hours: 7:59PM EDT

Stock chart is not supported by your current browser
Previous Close44.22
Bid44.06 x 1000
Ask45.00 x 1100
Day's Range43.22 - 45.09
52 Week Range20.10 - 300.00
Avg. Volume1,595,717
Market Cap4.318B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est79.30
Trade prices are not sourced from all markets
  • Inner Spirit Holdings Announces Six New Licences for Spiritleaf Retail Cannabis Stores in Alberta And Opening of New Spiritleaf Corporate Store in Jasper
    CNW Group11 hours ago

    Inner Spirit Holdings Announces Six New Licences for Spiritleaf Retail Cannabis Stores in Alberta And Opening of New Spiritleaf Corporate Store in Jasper

    CALGARY, July 16, 2019 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or the "Company") (CSE:ISH.CN - News), a Canadian company establishing a national network of retail cannabis stores under its Spiritleaf brand, today announced it has received six additional licences from Alberta Gaming, Liquor and Cannabis (the "AGLC") for retail cannabis stores in the province. The Company also announced that its corporate-owned retail cannabis store in Jasper, Alberta located at 618 Patricia Street is expected to open on Monday, July 22. Please visit for more information, including operating hours. The newly licensed locations include Spiritleaf retail cannabis stores in Beaumont, Calgary (Bow Trail), Calgary (Chinook), Edmonton (Ironstone), Grande Prairie and Medicine Hat, Alberta.

  • Cannabis Outlook From OrganiGram’s Earnings Report
    Market Realist13 hours ago

    Cannabis Outlook From OrganiGram’s Earnings Report

    On Monday, OrganiGram (OGI) reported its third-quarter earnings. Following the company's earnings, we reported how it performed in the third quarter. To learn more, read OrganiGram’s Third-Quarter Earnings. Interestingly, OrganiGram stressed that the growth would be heavily driven by retail stores opening in Ontario and Quebec. The company stated that legalizing edibles and derivative products […]

  • Organigram a Canadian Pot Rarity After Four Profitable Quarters
    Bloomberg16 hours ago

    Organigram a Canadian Pot Rarity After Four Profitable Quarters

    (Bloomberg) -- With four quarters of profitability under its belt, Organigram Holdings Inc. is an anomaly in the Canadian cannabis market.Organigram has higher margins than most of its peers and one of the lowest costs per gram in the industry even though it grows indoors, generally considered the most expensive method of production. Chief Executive Officer Greg Engel attributes this to its ability to get higher yields from its pot plants than companies that grow in greenhouses, as well as its automated packaging lines.“We built a facility and designed a facility that was very focused on high-quality product because we felt there was a market opportunity that was sustainable,” Engel said in an interview at Bloomberg’s Toronto office.Organigram’s streak of profitability comes as the industry undergoes a period of significant upheaval. CannTrust Holdings Inc., previously considered one of the more reputable pot companies, plunged 48% last week after Canadian regulators said it grew cannabis in unlicensed areas of its greenhouse, forcing it to halt all sales and shipments of its products.That came less than a week after Canopy Growth Corp. fired co-CEO Bruce Linton amid shrinking margins and a C$323 million net loss in its most recent quarter.Lower ValuationMoncton, New Brunswick-based Organigram, meanwhile, reported its fourth consecutive quarter on Monday of positive adjusted earnings before interest, taxes, depreciation and amortization, or Ebitda. Revenue of C$25 million ($19 million) missed estimates and gross margin fell to 50% from 60% in the previous quarter, but Eight Capital analyst Graeme Kreindler said he views this as an “isolated event” related to a temporary change in cultivation protocols and the timing of shipments to provinces.Organigram said it cost 95 cents to produce a gram of dried flower in its most recent quarter. That was up from 65 cents in the previous quarter but still compares favorably with C$1.42 at Aurora Cannabis Inc. and $1.48 at Tilray Inc.No other large Canadian pot producer has managed to post such a long string of positive Ebitda. However, although it’s one of the best-performing pure-play pot stocks this year, up 64%, its valuation as measured by its price-to-sales ratio is well below those of its largest competitors.Engel is unperturbed. “At the end of the day, the worst thing that can happen to a company is you’ve got an artificial stock price that you can’t sustain,” Engel said.Competitors also spend a lot on stock promotion, he said. This “may in the short term be helping their stock price, but I’m not sure that’s sustainable without ongoing spending,” he said.The problems at CannTrust and Canopy signal a shakeout in an industry that’s still maturing nine months after Canada legalized recreational pot. Organigram is lucky because it had its wake-up call early, said Engel.The company had to recall several lots of its medical pot in late 2016 and early 2017 after it was found to contain an unapproved pesticide. Engel, who was CEO of Tilray Inc. at the time, was hired after the recall to “make a major cultural shift,” he said.“As a result of that recall, we had monthly ongoing inspections by regulators, and historically the industry was always complaining or defensive about the inspections,” Engel said. “My approach was to embrace them. At the end of the day it’s a partnership, not an adversarial relationship.”In the interview, Engel shared his views of the nascent industry:Beverages and EdiblesOrganigram isn’t being coy about its desire for a partner that can help it develop cannabis-infused beverages, similar to Constellation Brands Inc.’s investment in Canopy, Tilray’s partnership with Anheuser-Busch InBev SA or Hexo Corp.’s joint venture with Molson Coors Brewing Co.Organigram has developed a rapid-onset technology that will allow its drinks to take effect within 10 to 15 minutes, similar to alcohol, and has also created a flavorless cannabis powder that can be added to any beverage.“We wanted to go to these negotiations offering as much as possible,” Engel said. Organigram is seeking a partner from the alcohol industry that can help it develop beverages infused with THC, the cannabis compound that gets you high. It’s also seeking a consumer packaged goods partner for drinks infused with CBD, a non-intoxicating substance that’s thought to have health and wellness properties.BiosyntheticsEngel hopes Organigram’s investment in Montreal-based Hyasynth Biologicals Inc. will also help it lure a partner. Hyasynth is developing large-scale biosynthetic production of cannabinoids, or the active compounds found in cannabis. This method, which uses yeast to produce the compounds in a lab, is cheaper than extracting them from plants and will help lower production costs for products like beverages, edibles and vape pens, said Engel.U.S. Market“We’re very actively looking at the CBD market in the U.S.,” where the substance is legal at the federal level as long as it’s derived from hemp with very low THC content, Engel said. Organigram doesn’t plan to grow its own hemp but is looking at a range of possibilities, including investments in existing brands, products and companies.Corporate GovernanceOrganigram has a fully independent board of directors, a rarity in the cannabis sector. The CEO sees good corporate governance as essential to a well-run pot company.“This is an industry that’s still very much moving from founders and executives being chairmen or multiple insiders on boards, and I think some of the challenges we’ve seen in the industry have been because of a lack of governance,” he said. “You have to have independent governance that has oversight and holds management accountable.”To contact the reporter on this story: Kristine Owram in Toronto at kowram@bloomberg.netTo contact the editors responsible for this story: Brad Olesen at, ;David Scanlan at, Jacqueline ThorpeFor more articles like this, please visit us at©2019 Bloomberg L.P.

  • U.S. CBD Sales to Grow an Average of 107% Annually Through 2023
    Motley Fool3 days ago

    U.S. CBD Sales to Grow an Average of 107% Annually Through 2023

    A new report projects nearly $24 billion in U.S. cannabidiol sales by 2023.

  • 3 Pot Stocks Short-Sellers Are Targeting
    Motley Fool6 days ago

    3 Pot Stocks Short-Sellers Are Targeting

    Pessimism is peaking for these three popular marijuana growers.

  • CNW Group6 days ago

    Zenabis Closes $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

    VANCOUVER, July 11, 2019 /CNW/ - Zenabis Global Inc.'s (TSX:ZENA.TO - News) ("Zenabis" or the "Company") wholly-owned subsidiary, Zenabis Ltd., has closed its previously-announced non-dilutive financing via a pre-paid supply agreement with High Park Holdings Ltd. ("High Park") (the "Supply Agreement"), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY - News) ("Tilray"). The terms of the Supply Agreement were previously disclosed in a news release dated July 2, 2019.

  • Business Wire6 days ago

    Tilray® Imports GMP-Certified Standardized Medical Cannabis Oil Into Ireland

    Tilray Inc. (TLRY:NASDAQ), a global pioneer in cannabis cultivation, processing and distribution, today announced that it has successfully imported Good Manufacturing Practices (GMP)-certified finished medical cannabis oral solutions into Ireland intended for nationwide distribution.

  • CNW Group7 days ago

    European Expansion of Cannvas Continues With Strong Focus on Intelligent Cannabis Education for Emerging $8B Market

    TORONTO, July 10, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE:MTEC.CN - News) (Frankfurt: 3CM)  (OTCPK:CANVF - News), a leading digital cannabis education and analytics company, is pleased to announce its planned expansion into Europe is on track with a renewed focus on providing consumer-facing intelligent cannabis education to potential and active medical and adult-use cannabis consumers through its international cannabis education platform Cannvas.Me. With its expansion into Germany underway, Cannvas is turning their attention to the United Kingdom as well as other emerging cannabis markets across the EU.

  • CannTrust Fell, Sent Other Cannabis Stocks Into the Red
    Market Realist8 days ago

    CannTrust Fell, Sent Other Cannabis Stocks Into the Red

    On Monday, CannTrust Holdings (CTST) stock fell almost 22.6%. The sell-off was driven by a negative compliance report from Health Canada.

  • Marijuana's "Big Four" Stocks Will Likely Lose Money in 2020
    Motley Fool8 days ago

    Marijuana's "Big Four" Stocks Will Likely Lose Money in 2020

    Rapid sales growth won't save these popular pot stocks from another year of red ink.

  • Baystreet9 days ago

    Booming European CBD Sales Signal a New Potentially Multi-Billion-Dollar Market

    Thanks to a trending new use as a tobacco substitute cannabidiol (CBD) sales are exploding across Europe. ...